TRIB1 confers therapeutic resistance in GBM cells by activating the ERK and Akt pathways by Karnika Singh, Chunhua Han, Jessica L. Fleming, Aline P. Becker, Joseph McElroy, Tiantian Cui, Benjamin Johnson, Ashok Kumar, Ebin Sebastian, Christian A. Showalter, Morgan S. Schrock, Matthew K. Summers, Valesio Becker, Zhen-yue Tong, Xiaomei Meng, Heather R. Manring, Monica Venere, Erica H. Bell, Pierre A. Robe, A. L. Grosu, S. Jaharul Haque, Arnab Chakravarti

Get full text